CAS RN: 149908-53-2

AZIMILIDE

Product Availability

Choose a grade to view its available package options.

8 package records6 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251115 10mg Out of stock 15 business days Inquiry
Batchno.20250214 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250413 100mg In stock Shanghai Inquiry
Batchno.20251130 10mg In stock Shanghai Inquiry
Batchno.20250223 250mg Out of stock Inquiry
Batchno.20250206 25mg In stock Shanghai Inquiry
Batchno.20251026 50mg In stock Shanghai Inquiry
Batchno.20250910 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS149908-53-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

149908-53-2 / 1-[(E)-[5-(4-chlorophenyl)furan-2-yl]methylideneamino]-3-[4-(4-methylpiperazin-1-yl)butyl]imidazolidine-2,4-dione

Standard CAS: 149908-53-2 Multi CAS: No

Basic Information

CAS
149908-53-2
Multi CAS
No
Molecular Formula
C23H28ClN5O3
Molecular Weight
458.000000
Exact Mass
457.188068
SMILES
CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)/N=C/C3=CC=C(O3)C4=CC=C(C=C4)Cl
InChI
InChI=1S/C23H28ClN5O3/c1-26-12-14-27(15-13-26)10-2-3-11-28-22(30)17-29(23(28)31)25-16-20-8-9-21(32-20)18-4-6-19(24)7-5-18/h4-9,16H,2-3,10-15,17H2,1H3/b25-16+
InChIKey
MREBEPTUUMTTIA-PCLIKHOPSA-N

Computed Properties

Structural Parameters

Heavy atom count
32
Aromatic heavy atom count
11
Fraction Csp3
0.43
Rotatable bonds
8
H-bond acceptors
6
Molar refractivity
123.73
TPSA
72.6

LogP / Solubility

WLOGP
3.23
MLOGP
2.87
XLogP3
3.2
Consensus LogP
3.1
Log S (ESOL)
-4.44
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.64
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.27
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.22

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us